Product Information
DILTIAZEM 24H ER(LA) 300 MG TB is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $1.7746 per EA under NDC 70436019806. Its NADAC has been published 160 times since May 3, 2023.
FDA first approved this application on Mar 7, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436019806
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216439FDA Approved
3/7/2023
TE Code
AB
On Market Since
3/20/2023
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24H ER(LA) 300 MG TB has been published 160 times since May 3, 2023, and over the history we have for it it has declined 43.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7746 per EA |
|---|---|
| All-time high | $3.1197 (Aug 16, 2023) |
| All-time low | $1.2965 (Jan 21, 2026) |
| 52-week high | $2.9349 |
| 52-week low | $1.2965 |
| Median price | $2.4080 |
| Average price | $2.3533 |
| Largest weekly change | +33.9% (Oct 23, 2024) |
| Weeks tracked | 160 |
| Tracking since | May 3, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
+18.0%
1Y
-39.5%
3Y
-43.1%
5Y
N/A
All
-43.1%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DILTIAZEM 24H ER(LA) 300 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(LA) 300 MG TB, manufactured by Slate Run Pharmaceuticals LLC, is $1.7746 per EA (NDC 70436019806), effective May 20, 2026.
How has the price of DILTIAZEM 24H ER(LA) 300 MG TB changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24H ER(LA) 300 MG TB has declined 43.1%. It has been tracked across 160 weekly CMS publications since May 3, 2023.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(LA) 300 MG TB?
Since May 3, 2023, the NADAC for DILTIAZEM 24H ER(LA) 300 MG TB has ranged from a low of $1.2965 (Jan 21, 2026) to a high of $3.1197 (Aug 16, 2023), with a median of $2.4080 per EA.
Are there cheaper alternatives to DILTIAZEM 24H ER(LA) 300 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 24H ER(LA) 300 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures DILTIAZEM 24H ER(LA) 300 MG TB?
DILTIAZEM 24H ER(LA) 300 MG TB (NDC 70436019806) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.